Beta-2 adrenergic agonist
Showing 1 - 25 of >10,000
Thermogenesis Trial in Basel (Fenoterol, Mild cold exposure)
Recruiting
- Thermogenesis
- Fenoterol
- Mild cold exposure
-
Basel, SwitzerlandUniversity Hospital Basel, Dept. of Endocrinology
Apr 27, 2022
Type 2 Diabetes, Obesity Trial in Sherbrooke (drug, other, diagnostic test, procedure)
Recruiting
- Type 2 Diabetes
- Obesity
- Formoterol Fumarate 12 micrograms Inhalation Powder
- +8 more
-
Sherbrooke, Quebec, CanadaCentre de recherche du CHUS
Sep 22, 2022
Healthy Trial in Maastricht (Clenbuterol Hydrochloride, Placebos)
Completed
- Healthy
- Clenbuterol Hydrochloride
- Placebos
-
Maastricht, Limburg, NetherlandsMaastricht University
Nov 28, 2022
Urgency Urinary Incontinence Trial in United States (Beta3-Agonists, Adrenergic, OnabotulinumtoxinA 100 UNT [Botox])
Not yet recruiting
- Urgency Urinary Incontinence
- Beta3-Agonists, Adrenergic
- OnabotulinumtoxinA 100 UNT [Botox]
-
Birmingham, Alabama
- +4 more
Mar 28, 2023
Moderate to Severe Asthma Exacerbation Trial in Poitiers (Standard Nebulization, A - Vibrating mesh nebulization, B - Vibrating
Not yet recruiting
- Moderate to Severe Asthma Exacerbation
- Standard Nebulization
- +2 more
-
Poitiers, FranceUniversity Hospital of Poitiers
Jan 11, 2023
Healthy Trial in Edmonton (Salbutamol 400mcg, Budesonide/formoterol, Placebo)
Recruiting
- Healthy
- Salbutamol 400mcg
- +2 more
-
Edmonton, Alberta, CanadaClinical Physiology Laboratory
Sep 5, 2023
Hypertrophy, Physiologic Hypertrophy, Physical Activity Trial in Copenhagen (Formoterol, Terbutaline, Placebo)
Unknown status
- Hypertrophy
- +2 more
- Formoterol
- +2 more
-
Copenhagen, DenmarkAugust Krogh Building
Mar 24, 2020
Spinal Cord Injury, Respiratory Muscle Weakness Trial in Bronx (Oral Albuterol Extended Release, Placebo)
Active, not recruiting
- Spinal Cord Injury
- Respiratory Muscle Weakness
- Oral Albuterol Extended Release
- Placebo
-
Bronx, New YorkJames J. Peters VA Medical Center, Bronx, NY
Nov 8, 2022
Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo (behavioral, drug, other)
Recruiting
- Plasma Cell Myeloma
- +3 more
- Behavioral Intervention
- +6 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 5, 2022
Opioid Use Disorder, Opioid Withdrawal Trial (BXCL501 (180 micrograms), BXCL501 (240 micrograms), Placebo)
Not yet recruiting
- Opioid Use Disorder
- Opioid Withdrawal
- BXCL501 (180 micrograms)
- +3 more
- (no location specified)
Jan 24, 2023
Type 2 Diabetes Trial (Clenbuterol Hydrochloride, Placebo)
Not yet recruiting
- Type 2 Diabetes
- Clenbuterol Hydrochloride
- Placebo
- (no location specified)
Jun 2, 2021
Transient Tachypnea of the Newborn Trial (Epinephrine Inhalation Solution, Salbutamol, Saline Inhalants)
Completed
- Transient Tachypnea of the Newborn
- Epinephrine Inhalation Solution
- +2 more
- (no location specified)
Aug 7, 2021
Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics Trial in Seoul (Mirabegron
Active, not recruiting
- Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics
- Mirabegron (beta3-adrenoceptor agonist), Anticholinergics
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Feb 15, 2023
Reversibility of Bronchial Obstruction in Children Born Preterm
Recruiting
- Bronchopulmonary Dysplasia
- +6 more
-
Prague, CzechiaFirst faculty of Medicine, Charles university.
Oct 29, 2023
Healthy Volunteers Trial in New York (Clonidine Pill)
Withdrawn
- Healthy Volunteers
- Clonidine Pill
-
New York, New YorkWeill Cornell Medicine
Jul 14, 2021
Hypertrophy, Left Ventricular Trial in Worldwide (drug, procedure, radiation)
Active, not recruiting
- Hypertrophy, Left Ventricular
- mirabegron
- +6 more
-
Brussels, Belgium
- +8 more
Sep 28, 2021
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +4 more
- Biopsy
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 14, 2023
Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder Trial in Palo Alto, San Francisco (Tolterodine Tartrate ER,
Recruiting
- Urinary Incontinence, Urge
- +5 more
- Tolterodine Tartrate ER
- +2 more
-
Palo Alto, California
- +1 more
Dec 7, 2022
COPD, High-flow Nasal Cannula Trial in Poitiers (salbutamol)
Unknown status
- Chronic Obstructive Pulmonary Disease
- High-flow Nasal Cannula
-
Poitiers, FranceC.H.U. de Poitiers
Feb 11, 2019
Healthy Trial (Training, Formoterol, Placebo)
Unknown status
- Healthy
- Training
- +2 more
- (no location specified)
Nov 3, 2020
Bronchial Asthma Trial in Chandigarh (Single Inhalation technique, Tidal inhalation technique)
Recruiting
- Bronchial Asthma
- Single Inhalation technique
- Tidal inhalation technique
-
Chandigarh, India
- +1 more
Jun 23, 2022
Alzheimer's Disease, Cognitive Dysfunction Trial in Palo Alto (Formoterol A, Formoterol B ())
Withdrawn
- Alzheimer's Disease
- Cognitive Dysfunction
- Formoterol A
- Formoterol B (placebo)
-
Palo Alto, CaliforniaVA Palo Alto Health Care System
Sep 14, 2020
Voiding Disorders, Overactive Bladder Trial (Beta3-Agonists, Adrenergic, Anticholinergic drug, Solifenacin)
Not yet recruiting
- Voiding Disorders
- Overactive Bladder
- Beta3-Agonists, Adrenergic
- Anticholinergic drug, Solifenacin
- (no location specified)
Feb 13, 2022